13F Holdings
中文EN

BAKER BROS. ADVISORS LP

NEW YORK NY · SEC CIK 0001263508

2026Q22026Q1 9 earlier quarters 🔒
$19.96B2026Q2 reported value
84Positions
72.8%Top 10 weight · largest 17.5%
6 / 8New / sold out
Reported value over time$19.96B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

INCY 17.5%
ONC 12.6%
RVMD 10.7%
MDGL 5.8%
ACAD 5.4%
KYMR 5.0%
INSM 4.7%
CELC 4.2%
KOD 3.9%
RYTM 3.1%

2026Q2 top buys estimated at quarter-end value

RVMD Added+$353.58M
INSM Added+$146.60M
IDYA Added+$39.64M
FTH New+$32.16M
RLAY Added+$31.18M

2026Q2 top sells estimated at quarter-end value

EWTX Reduced-$116.78M
ABVX Sold out-$97.52M
SMMT Reduced-$52.52M
SYRE Sold out-$50.44M
Centessa Pharmac Sold out-$26.64M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
INCY Incyte Corporation $3.49B17.48%30,762,330 17,9180.1% $2.03M Added
ONC BeOne Medicines Ltd. $2.51B12.57%8,801,567 2,5140.0% $716,415 Added
RVMD Revolution Medicines, Inc. $2.14B10.74%11,443,357 1,888,00019.8% $353.58M Added
MDGL Madrigal Pharmaceuticals, Inc. $1.15B5.77%2,143,131 1,4300.1% $767,838 Added
ACAD ACADIA Pharmaceuticals Inc. $1.09B5.44%42,912,904 16,2140.0% $410,214 Added
KYMR Kymera Therapeutics, Inc. $992.73M4.97%8,657,242 00.0% — Unchanged
INSM Insmed Incorporated $937.84M4.70%8,796,111 1,375,00018.5% $146.60M Added
CELC Celcuity Inc. $828.15M4.15%7,915,792 00.0% — Unchanged
KOD Kodiak Sciences Inc. $776.05M3.89%19,919,186 00.0% — Unchanged
RYTM Rhythm Pharmaceuticals, Inc. $622.27M3.12%5,604,483 00.0% — Unchanged
PRAX Praxis Precision Medicines, Inc. $586.95M2.94%1,753,198 00.0% — Unchanged
ALKS Alkermes plc $524.59M2.63%10,012,267 00.0% — Unchanged
SMMT Summit Therapeutics Inc. $477.70M2.39%32,786,348 -3,604,715-9.9% -$52.52M Reduced
GRAL GRAIL, Inc. $275.03M1.38%4,028,614 00.0% — Unchanged
ABCL AbCellera Biologics Inc. $259.15M1.30%33,012,138 2,736,2009.0% $21.48M Added
IMVT Immunovant, Inc. $209.42M1.05%5,435,220 -22,661-0.4% -$873,128 Reduced
IDYA IDEAYA Biosciences, Inc. $186.72M0.94%5,010,030 1,063,51526.9% $39.64M Added
KNSA Kiniksa Pharmaceuticals International, plc $181.28M0.91%2,834,643 8,3970.3% $536,988 Added
ROIV Roivant Sciences Ltd. $166.93M0.84%4,716,831 -150,892-3.1% -$5.34M Reduced
ARWR Arrowhead Pharmaceuticals, Inc. $162.43M0.81%1,992,783 00.0% — Unchanged
IONS Ionis Pharmaceuticals, Inc. $162.36M0.81%2,047,727 00.0% — Unchanged
EWTX Edgewise Therapeutics, Inc. $150.40M0.75%3,701,719 -2,874,221-43.7% -$116.78M Reduced
REPL Replimune Group, Inc. $122.27M0.61%11,045,336 00.0% — Unchanged
NRIX Nurix Therapeutics, Inc. $113.02M0.57%4,658,556 00.0% — Unchanged
STOK Stoke Therapeutics, Inc. $109.18M0.55%3,336,697 00.0% — Unchanged
GLUE Monte Rosa Therapeutics, Inc. $105.17M0.53%4,345,736 00.0% — Unchanged
IMTX Immatics N.V. $96.32M0.48%9,508,565 -1,408,128-12.9% -$14.26M Reduced
DNLI Denali Therapeutics Inc. $96.05M0.48%3,734,336 2,6410.1% $67,927 Added
— Crinetics Pharmaceuticals, Inc. $87.99M0.44%2,351,465 00.0% — Unchanged
DNTH Dianthus Therapeutics, Inc. $83.07M0.42%852,164 00.0% — Unchanged
GPCR Structure Therapeutics Inc. $76.88M0.39%1,432,529 00.0% — Unchanged
CELC Celcuity Inc. $69.16M0.35%30,750,000 00.0% — Unchanged
RAPP Rapport Therapeutics, Inc. $64.47M0.32%1,547,090 00.0% — Unchanged
ALMS Alumis Inc. $56.63M0.28%2,012,500 00.0% — Unchanged
PRLD Prelude Therapeutics Inc. $53.96M0.27%10,123,824 00.0% — Unchanged
RLAY Relay Therapeutics, Inc. $52.89M0.27%2,826,783 1,666,666143.7% $31.18M Added
MIRM Mirum Pharmaceuticals, Inc. $52.21M0.26%445,975 00.0% — Unchanged
BCYC Bicycle Therapeutics plc $46.15M0.23%10,885,357 00.0% — Unchanged
ELVN Enliven Therapeutics, Inc. $45.94M0.23%905,191 00.0% — Unchanged
CLDX Celldex Therapeutics, Inc. $44.00M0.22%1,182,611 517,24177.7% $19.25M Added
VRDN Viridian Therapeutics, Inc. $43.78M0.22%2,383,025 411,34720.9% $7.56M Added
DSGN Design Therapeutics, Inc. $38.76M0.19%2,678,430 92,4523.6% $1.34M Added
TRDA Entrada Therapeutics, Inc. $37.34M0.19%5,072,730 00.0% — Unchanged
FTH Faeth Therapeutics, Inc. $32.16M0.16%1,286,411 1,286,411— $32.16M New
AKTS Aktis Oncology, Inc. $32.11M0.16%996,351 00.0% — Unchanged
NGNE Neurogene Inc. $31.19M0.16%991,691 00.0% — Unchanged
JBIO Jade Biosciences, Inc. $27.34M0.14%1,230,426 -410,711-25.0% -$9.13M Reduced
TSHA Taysha Gene Therapies, Inc. $27.27M0.14%4,004,756 00.0% — Unchanged
RCUS Arcus Biosciences, Inc. $26.05M0.13%844,816 429,195103.3% $13.23M Added
IRON Disc Medicine, Inc. $25.57M0.13%349,657 00.0% — Unchanged
ABSI Absci Corporation $24.74M0.12%2,134,803 00.0% — Unchanged
GENB Generate Biomedicines, Inc. $24.02M0.12%1,423,602 00.0% — Unchanged
DBVT DBV Technologies S.A. $23.97M0.12%1,461,425 00.0% — Unchanged
XENE Xenon Pharmaceuticals Inc. $22.35M0.11%370,208 00.0% — Unchanged
TECX Tectonic Therapeutic, Inc. $20.89M0.10%607,788 00.0% — Unchanged
CERS Cerus Corporation $18.67M0.09%6,395,431 -3,612,914-36.1% -$10.55M Reduced
CTMX CytomX Therapeutics, Inc. $18.66M0.09%4,975,826 00.0% — Unchanged
DYN Dyne Therapeutics, Inc. $18.07M0.09%813,449 00.0% — Unchanged
CYTK Cytokinetics, Incorporated $18.00M0.09%211,267 211,267— $18.00M New
XNCR Xencor, Inc. $17.74M0.09%1,102,106 00.0% — Unchanged
SION Sionna Therapeutics, Inc. $17.60M0.09%400,000 00.0% — Unchanged
NTLA Intellia Therapeutics, Inc. $15.74M0.08%930,232 930,232— $15.74M New
PBLS Parabilis Medicines, Inc. $13.69M0.07%500,000 500,000— — First reported
MPLT MapLight Therapeutics, Inc. $13.07M0.07%364,705 00.0% — Unchanged
AVLN Avalyn Pharma Inc. $11.52M0.06%350,000 350,000— — First reported
EVMN Evommune, Inc. $11.26M0.06%847,390 00.0% — Unchanged
BNTX BioNTech SE $11.14M0.06%119,743 00.0% — Unchanged
TNGX Tango Therapeutics, Inc. $10.42M0.05%333,333 333,333— $10.42M New
AVTX Avalo Therapeutics, Inc. $10.16M0.05%550,000 550,000— $10.16M New
— Sera Prognostics, Inc. $10.01M0.05%5,498,170 00.0% — Unchanged
VSTM Verastem, Inc. $9.55M0.05%2,499,338 1,914,581327.4% $7.31M Added
SGMT Sagimet Biosciences Inc. $7.37M0.04%952,996 00.0% — Unchanged
EIKN Eikon Therapeutics, Inc. $7.25M0.04%555,555 00.0% — Unchanged
LBRX LB Pharmaceuticals Inc. $6.49M0.03%200,000 00.0% — Unchanged
— vTv Therapeutics, Inc. $5.58M0.03%148,314 00.0% — Unchanged
WVE Wave Life Sciences Ltd. $4.78M0.02%822,638 00.0% — Unchanged
TARA Protara Therapeutics, Inc. $3.71M0.02%971,614 00.0% — Unchanged
— TScan Therapeutics, Inc. $2.73M0.01%2,784,792 00.0% — Unchanged
IMNM Immunome, Inc. $1.17M0.01%55,306 55,306— $1.17M New
— Skye Bioscience, Inc. $1.09M0.01%1,575,243 00.0% — Unchanged
SANA Sana Biotechnology, Inc. $1.08M0.01%310,483 00.0% — Unchanged
— Aligos Therapeutics, Inc. $479,2270.00%83,055 00.0% — Unchanged
TYRA Tyra Biosciences, Inc. $338,7880.00%10,607 00.0% — Unchanged
— Surrozen, Inc. Warrants @ $172.50 8/11/2026 (15 FOR 1) $13,7500.00%833,333 00.0% — Unchanged
ABVX Abivax S.A. $00.00%0 -875,796-100.0% -$97.52M Sold out
SYRE Spyre Therapeutics, Inc. $00.00%0 -1,000,000-100.0% -$50.44M Sold out
— Centessa Pharmaceuticals plc $00.00%0 -670,751-100.0% -$26.64M Sold out
IMCR Immunocore Holdings plc $00.00%0 -734,397-100.0% -$22.14M Sold out
CTNM Contineum Therapeutics, Inc. $00.00%0 -1,420,838-100.0% -$18.56M Sold out
ARGX argenx SE $00.00%0 -25,174-100.0% -$18.38M Sold out
CMPS COMPASS Pathways plc $00.00%0 -2,344,720-100.0% -$12.97M Sold out
PHVS Pharvaris N.V. $00.00%0 -375,000-100.0% -$10.59M Sold out